Category: Fresenius Medical CareSyndicate content

Fresenius Medical takes over U.S. healthcare group Cogent

November 13, 2014 by MassDevice

Fresenius Medical Care acquires Cogent Healthcare and its specialty physicians business for an unspecified amount as it looks to build a $5 billion coordinated care operation.

Fresenius Medical takes over U.S. healthcare group Cogent

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Fresenius ends Russia joint venture, feels impact of Ukraine crisis

November 7, 2014 by Brad Perriello

Economic sanctions against Russia over the Ukraine crisis prompt Fresenius to scrap a Russian joint venture.

Fresenius ends Russia joint venture, feels impact of Ukraine crisis

Conor MedSystems can't slip $100 million breach of contract lawsuit | Medtech legal news for the week of May 26, 2014

May 26, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: J&J's Conor MedSystems can't slip $100M Biotronik lawsuit; Supreme Court declines review of Baxter/Fresenius patent row; Medtronic, Edwards ink $750M heart valve settlement; Pa. Supreme Court to review $28M Zimmer verdict; Laid off Italian workers sue Haemonetics.

J&J's Conor MedSystems can't slip $100M Biotronik lawsuit

May 20, 2014 by Brad Perriello

J&J's Conor Medsystems can't slip $100M Biotronik lawsuit

Supreme Court declines review of Baxter/Fresenius patent row

May 19, 2014 by Brad Perriello

Fresenius escapes for good a $24 million patent infringement loss to dialysis rival Baxter International after the U.S. Supreme court declines to review the case.

Supreme Court declines review of Baxter/Fresenius patent row

Fresenius' renal research division gets a makeover

March 26, 2014 by Arezu Sarvestani

Dialysis services provider Fresenius gives its renal research arm a new look, renaming it "Frenova" and reasserting its focus on new product development.

Fresenius forms renal research arm

Dialysis giant Fresenius (NYSE:FMS) re-introduced its renal research branch, renaming it "Frenova" and reiterating the group's commitment to developing novel therapies.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Biomet puts itself back on public market | Medtech Wall Street news for the week of Mar. 10, 2014

March 13, 2014 by MassDevice staff

Here's a look at some of the top Wall Street stories for medical device companies this week.

Biomet announces IPO plans

March 7, 2014 by Brad Perriello

Biomet announces IPO plans

Biomet is planning to put itself back on the public market after a 7-year run under private equity ownership, the orthopedics giant said today.

Siemens, GE named among worst-performing device makers of the year | MassDevice.com On Call

March 12, 2014 by Arezu Sarvestani

QMed releases a list of the 5 worst-performing medical device companies of early 2014, including Siemens, GE and Fresenius, among others.

MassDevice.com On Call

MASSDEVICE ON CALL — Medtech giants have seen Wall Street bumps so far this year, but several of the company's in the industry's top 40 haven't been so fortunate.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp